Recce Pharmaceuticals is commercializing a novel synthetic broad-spectrum antibiotic designed to overcome antimicrobial resistance. Its lead compound, RECCE 327, is one of the first entirely new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback